• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RNA 疗法:丰富的历史、多样的应用和无限的未来前景。

RNA therapy: rich history, various applications and unlimited future prospects.

机构信息

Department of Biochemistry, Chonnam National University Medical School, Hwasun, Jeollanam-do, 58128, Republic of Korea.

出版信息

Exp Mol Med. 2022 Apr;54(4):455-465. doi: 10.1038/s12276-022-00757-5. Epub 2022 Apr 19.

DOI:10.1038/s12276-022-00757-5
PMID:35440755
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9016686/
Abstract

RNA therapy refers to the treatment or prevention of diseases using RNA-based molecules. The recent advent of a series of effective messenger RNA-based vaccines in response to the COVID-19 pandemic has reignited research interest in RNA therapy. Based on the accumulated results of long-term research in the field of RNA therapy spanning several decades, therapeutic agents for various diseases are being rapidly developed. These therapeutics tend to target diseases that cannot be treated with other conventional drug groups, and several clinical studies are underway for a variety of RNA-based therapeutics against various incurable diseases. This review describes the history of several important discoveries in RNA biology and their impact on key developments in RNA therapy as well as the advantages of RNA therapy. In addition, it describes the action mechanisms and examples of drugs approved for RNA therapy. Finally, this review discusses methods for RNA drug delivery to target organs and cells. Given that RNA therapy is expected to advance and play an integral role in the development of novel therapeutic agents for human diseases in the future, this review is designed to offer an updated reference point for researchers in this field.

摘要

RNA 疗法是指使用基于 RNA 的分子来治疗或预防疾病。最近,一系列针对 COVID-19 大流行的有效信使 RNA 疫苗的出现,重新点燃了人们对 RNA 疗法的研究兴趣。基于 RNA 疗法领域几十年来积累的长期研究结果,针对各种疾病的治疗药物正在迅速开发中。这些疗法往往针对其他传统药物类别无法治疗的疾病,并且正在进行多种针对各种不治之症的基于 RNA 的治疗方法的临床研究。本综述描述了 RNA 生物学的几个重要发现的历史及其对 RNA 疗法关键发展的影响,以及 RNA 疗法的优势。此外,它还描述了已批准用于 RNA 疗法的药物的作用机制和实例。最后,本文讨论了将 RNA 药物递送到靶器官和细胞的方法。鉴于 RNA 疗法有望在未来推进并在新型人类疾病治疗药物的开发中发挥重要作用,因此本综述旨在为该领域的研究人员提供一个更新的参考点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47f4/9076888/006c0cdd003b/12276_2022_757_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47f4/9076888/91e9bea5615c/12276_2022_757_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47f4/9076888/8e6bfb9d4fd1/12276_2022_757_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47f4/9076888/7bd14fbc922a/12276_2022_757_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47f4/9076888/6c0a3153d621/12276_2022_757_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47f4/9076888/c3f6ef85da57/12276_2022_757_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47f4/9076888/0b3b37e3d50f/12276_2022_757_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47f4/9076888/006c0cdd003b/12276_2022_757_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47f4/9076888/91e9bea5615c/12276_2022_757_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47f4/9076888/8e6bfb9d4fd1/12276_2022_757_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47f4/9076888/7bd14fbc922a/12276_2022_757_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47f4/9076888/6c0a3153d621/12276_2022_757_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47f4/9076888/c3f6ef85da57/12276_2022_757_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47f4/9076888/0b3b37e3d50f/12276_2022_757_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47f4/9076888/006c0cdd003b/12276_2022_757_Fig7_HTML.jpg

相似文献

1
RNA therapy: rich history, various applications and unlimited future prospects.RNA 疗法:丰富的历史、多样的应用和无限的未来前景。
Exp Mol Med. 2022 Apr;54(4):455-465. doi: 10.1038/s12276-022-00757-5. Epub 2022 Apr 19.
2
RNA therapeutics history and future perspectives.RNA 疗法的历史与未来展望。
Prog Mol Biol Transl Sci. 2024;203:99-114. doi: 10.1016/bs.pmbts.2024.01.004. Epub 2024 Jan 24.
3
The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.新冠疫苗的快速研发和早期成功为加速癌症治疗机制带来了希望。
Arch Razi Inst. 2021 Mar;76(1):1-6. doi: 10.22092/ari.2021.353761.1612. Epub 2021 Mar 1.
4
Antisense RNA Therapeutics: A Brief Overview.反义 RNA 治疗学:简要概述。
Methods Mol Biol. 2022;2434:33-49. doi: 10.1007/978-1-0716-2010-6_2.
5
mRNA-based therapeutic strategies for cancer treatment.基于信使 RNA 的癌症治疗策略。
Mol Ther. 2024 Sep 4;32(9):2819-2834. doi: 10.1016/j.ymthe.2024.04.035. Epub 2024 May 3.
6
Drug Discovery Strategies for SARS-CoV-2.针对 SARS-CoV-2 的药物研发策略。
J Pharmacol Exp Ther. 2020 Oct;375(1):127-138. doi: 10.1124/jpet.120.000123. Epub 2020 Jul 28.
7
RNA therapeutics for cardiovascular disease.心血管疾病的 RNA 疗法。
Curr Opin Cardiol. 2021 May 1;36(3):256-263. doi: 10.1097/HCO.0000000000000850.
8
Recent advances in delivering RNA-based therapeutics to mitochondria.线粒体递送 RNA 治疗药物的最新进展。
Expert Opin Biol Ther. 2022 Sep;22(9):1209-1219. doi: 10.1080/14712598.2022.2070427. Epub 2022 May 11.
9
RNA Coronaviruses' Outbreaks: Recent Progress on the SARS-CoV-2 Pandemic Diagnostic Tests, Vaccination and Therapeutics.RNA 冠状病毒的爆发:SARS-CoV-2 大流行诊断测试、疫苗接种和治疗的最新进展。
Mini Rev Med Chem. 2022;22(4):617-628. doi: 10.2174/1389557521666210422113915.
10
COVID-19: Prospective Challenges and Potential Vaccines.新型冠状病毒肺炎:潜在挑战与候选疫苗
Altern Ther Health Med. 2020 Aug;26(S2):72-78.

引用本文的文献

1
Managing Spinal Muscular Atrophy: A Look at the Biology and Treatment Strategies.脊髓性肌萎缩症的管理:生物学及治疗策略概述
Biology (Basel). 2025 Aug 1;14(8):977. doi: 10.3390/biology14080977.
2
Self-splicing RNA circularization facilitated by intact group I and II introns.由完整的I类和II类内含子促进的自我剪接RNA环化
Nat Commun. 2025 Aug 10;16(1):7376. doi: 10.1038/s41467-025-62607-y.
3
Trends and Commonalities of Approved and Late Clinical-Phase RNA Therapeutics.获批及临床后期RNA疗法的趋势与共性

本文引用的文献

1
Lipid-Based Nanoparticles in the Clinic and Clinical Trials: From Cancer Nanomedicine to COVID-19 Vaccines.临床及临床试验中的脂质纳米颗粒:从癌症纳米医学到新冠疫苗
Vaccines (Basel). 2021 Apr 8;9(4):359. doi: 10.3390/vaccines9040359.
2
Targeting non-coding RNAs for the treatment of retinal diseases.靶向非编码RNA治疗视网膜疾病
Mol Ther Nucleic Acids. 2021 Mar 1;24:284-293. doi: 10.1016/j.omtn.2021.02.031. eCollection 2021 Jun 4.
3
Inclisiran: First Approval.依洛尤单抗:首次获批
Pharmaceutics. 2025 Jul 12;17(7):903. doi: 10.3390/pharmaceutics17070903.
4
Precision photodamage of RNA and mitochondria for cancer therapy with upconversion nanoparticles.用于癌症治疗的上转换纳米粒子对RNA和线粒体的精确光损伤
Mikrochim Acta. 2025 Jul 29;192(8):537. doi: 10.1007/s00604-025-07332-5.
5
Bio-engineered microRNA-7 effectively interferes with the Akt3/p53 axis to suppress human non-small cell lung cancer.生物工程改造的微小RNA-7有效干扰Akt3/p53轴以抑制人类非小细胞肺癌。
Cancer Cell Int. 2025 Jul 2;25(1):250. doi: 10.1186/s12935-025-03856-1.
6
RNA-ssisting immunity to heal the heart: a new frontier in therapeutics.RNA辅助心脏修复免疫:治疗学的新前沿
Cardiol Plus. 2025 Apr-Jun;10(2):129-144. doi: 10.1097/CP9.0000000000000116. Epub 2025 Jun 24.
7
Discovery of Drugs Targeting Mutant p53 and Progress in Nano-Enabled Therapeutic Strategy for p53-Mutated Cancers.靶向突变型p53的药物发现及p53突变型癌症的纳米治疗策略进展
Biomolecules. 2025 May 26;15(6):763. doi: 10.3390/biom15060763.
8
Small Interfering RNA (siRNA) for Cardiorenal Disease: Mechanistic Insights from Preclinical and Clinical Studies.用于心肾疾病的小干扰RNA(siRNA):来自临床前和临床研究的机制见解
J Cardiovasc Transl Res. 2025 Jun 25. doi: 10.1007/s12265-025-10649-4.
9
Delivery strategies for RNA-targeting therapeutic nucleic acids and RNA-based vaccines against respiratory RNA viruses: IAV, SARS-CoV-2, RSV.针对呼吸道RNA病毒(甲型流感病毒、严重急性呼吸综合征冠状病毒2、呼吸道合胞病毒)的RNA靶向治疗性核酸和基于RNA的疫苗的递送策略
Mol Ther Nucleic Acids. 2025 May 20;36(3):102572. doi: 10.1016/j.omtn.2025.102572. eCollection 2025 Sep 9.
10
Small Interfering RNA (siRNA) in Dyslipidemia: A Systematic Review on Safety and Efficacy of siRNA.小干扰RNA(siRNA)在血脂异常中的应用:关于siRNA安全性和有效性的系统评价
J Exp Pharmacol. 2025 May 28;17:249-267. doi: 10.2147/JEP.S521579. eCollection 2025.
Drugs. 2021 Feb;81(3):389-395. doi: 10.1007/s40265-021-01473-6.
4
Self-amplifying RNA vaccines for infectious diseases.用于传染病的自我扩增 RNA 疫苗。
Gene Ther. 2021 Apr;28(3-4):117-129. doi: 10.1038/s41434-020-00204-y. Epub 2020 Oct 22.
5
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults.一项在成人中开展的 COVID-19 RNA 疫苗 BNT162b1 的 I/II 期研究。
Nature. 2020 Oct;586(7830):589-593. doi: 10.1038/s41586-020-2639-4. Epub 2020 Aug 12.
6
Advances in oligonucleotide drug delivery.寡核苷酸药物递送的进展。
Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11.
7
An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma.一种 RNA 疫苗在接受检查点抑制剂治疗的黑色素瘤中引发免疫反应。
Nature. 2020 Sep;585(7823):107-112. doi: 10.1038/s41586-020-2537-9. Epub 2020 Jul 29.
8
An mRNA Vaccine against SARS-CoV-2 - Preliminary Report.mRNA 疫苗对 SARS-CoV-2 的作用-初步报告。
N Engl J Med. 2020 Nov 12;383(20):1920-1931. doi: 10.1056/NEJMoa2022483. Epub 2020 Jul 14.
9
Phase 1-2 Trial of Antisense Oligonucleotide Tofersen for ALS.针对肌萎缩性侧索硬化症的反义寡核苷酸 Tofersen 的 1-2 期临床试验。
N Engl J Med. 2020 Jul 9;383(2):109-119. doi: 10.1056/NEJMoa2003715.
10
Single-Dose Pharmacokinetics and Pharmacodynamics of Transthyretin Targeting N-acetylgalactosamine-Small Interfering Ribonucleic Acid Conjugate, Vutrisiran, in Healthy Subjects.单次给药转甲状腺素蛋白靶向 N-乙酰半乳糖胺小干扰 RNA 偶联物,Vutrisiran,在健康受试者中的药代动力学和药效学。
Clin Pharmacol Ther. 2021 Feb;109(2):372-382. doi: 10.1002/cpt.1974. Epub 2020 Aug 13.